Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 18:20
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 20°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
¼·Î ¾ôÇô ÀÖ´Â À§ÇèÀÎÀÚ
ÀÓ¼¼Çü ±âÀÚ
2018-09-04 16:46
[Sub Story]
¿¡Á¦Æ¼¹Ìºê + ½ºÅ¸Æ¾ ¿¬±¸µé Á¾Çպм®Çß´õ´Ï¡¦
ÀÌ»óµ· ±âÀÚ
2018-09-04 16:17
[Sub Story]
¡®18¡¤18¡¤19¡¯ Çѱ¹ÀÎ ÀÌ»óÁöÁúÇ÷ÁõÀÇ ºñ¹Ð
ÀÌ»óµ· ±âÀÚ
2018-09-04 16:16
[Cover Story]
Á׻󵿸ưæȼº ÀÌ»óÁöÁúÇ÷Áõ Çѱ¹¿¡¼ ÅäÂøȵdzª?
ÀÌ»óµ· ±âÀÚ
2018-09-04 16:16
[Sub Story]
·Î¼ö¹Ù½ºÅ¸Æ¾Àº ¾î¶»°Ô ½ÉÇ÷°üÁúȯ À§Çè ÁÙ¿´³ª?
ÀÌ»óµ· ±âÀÚ
2018-09-04 16:03
¶óÀÎ
[Sub Story]
¾ÆÅ丣¹Ù½ºÅ¸Æ¾ °í°µµ¡¤°í¿ë·® ÁýÁß¿ä¹ýÀÇ ÀÓ»ó±Ù°Å
ÀÌ»óµ· ±âÀÚ
2018-09-04 15:53
[Sub Story]
¾Æ½Ã¾ÆÀÎ Àû¿ë °¡´ÉÇÑ ½ºÅ¸Æ¾ Àü·« Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2018-09-04 15:49
[Sub Story]
°íTG¡¤ÀúHDL ´ë»çÁõÈıº Áõ°¡ ÁÖ¹ü
ÀÌ»óµ· ±âÀÚ
2018-09-04 15:42
[Sub Story]
º¹ÇÕ ÀÌ»óÁöÁúÇ÷Áõ ¸¶¹ýÀÇ ÅºÈ¯Àº LDL¡¤TG¡¤HDL µ¿½ÃÁ¶Àý
ÀÌ»óµ· ±âÀÚ
2018-09-04 15:38
[Sub Story]
ÁöÁúÀÎÀÚ °ãÄ¡¸é ½ºÅ¸Æ¾À¸·Îµµ ¿ªºÎÁ·
ÀÌ»óµ· ±âÀÚ
2018-09-04 15:35
¶óÀÎ
[Sub Story]
HDL-C ¾à¹° ÇöÁÖ¼Ò´Â?
ÀÌ»óµ· ±âÀÚ
2018-09-04 15:31
[Sub Story]
CCB/ARB/½ºÅ¸Æ¾ º¹ÇÕÁ¦ ¾ÈÁ¤Àû ¡®ASCVD °ü¸®¡¯ ÀüȯÁ¡
ÀÓ¼¼Çü ±âÀÚ
2018-09-04 15:28
[Sub Story]
ÁöÁúÄ¡·áÁ¦°¡ Ç÷´ç°ÇÏÁ¦¸¦ ¸¸³ª¸é¡¦
ÀÓ¼¼Çü ±âÀÚ
2018-09-04 15:17
[Sub Story]
½ºÅ¸Æ¾°ú Ç×°íÇ÷¾ÐÁ¦ ½ÉÇ÷°üÁúȯ ¸Â¼³ ´ÜÀÏÆÀ ²Ù¸°´Ù
ÀÌ»óµ· ±âÀÚ
2018-09-04 15:13
[Drug Review]
·Î¼ö¹Ù½ºÅ¸Æ¾/¹ß»ç¸£Åº º¹ÇÕÁ¦, ȯÀÚƯ¼º µû¶ó ¸ÂÃãÄ¡·á °¡´É
ÀÌ»óµ· ±âÀÚ
2018-09-04 15:11
¶óÀÎ
[Conference Report]
PCSK9 ¾ïÁ¦Á¦, Lp(a) ³ôÀ»¼ö·Ï È¿°ú Å©´Ù
ÀÓ¼¼Çü ±âÀÚ
2018-09-04 15:09
[Conference Report]
Lp(a)¡¤¿°Áõµµ Á׻󵿸ưæÈÁõ ÀÓ»óÀû Ÿ±ê
ÀÓ¼¼Çü ±âÀÚ
2018-09-04 15:07
[Conference Report]
½ºÅÙÆ®Ç÷ÀüÁõ¡¤¿°Áõ¡¤È¯°æÀÎÀÚ °³¼±ÅëÇÑ Á׻󵿸ưæÈÁõ °ü¸®
ÀÓ¼¼Çü ±âÀÚ
2018-09-04 14:47
[Deep in Guideline]
ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÁöħ 2018³âÆÇ ¡®½Ã»çȸ¡¯ °¡´Ù
¹Ú¼±Çý
2018-09-04 14:39
[Deep in Guideline]
°íÇ÷¾Ð °¡À̵å¶óÀÎ ÃáÃßÀü±¹½Ã´ë
¹Ú¼±Çý ±âÀÚ
2018-09-04 14:17
-
1
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top